Literature DB >> 16043139

Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.

Judy P Q Zhu1, Wenjing Xu, Jesus A Angulo.   

Abstract

Methamphetamine (METH) causes damage in the striatum at pre- and post-synaptic sites. Exposure to METH induces long-term depletions of dopamine (DA) terminal markers such as tyrosine hydroxylase (TH) and DA transporters (DAT). METH also induces neuronal apoptosis in some striatal neurons. The purpose of this study is to demonstrate which occurs first, apoptosis of some striatal neurons or DA terminal toxicity in mice. This is important because the death of striatal neurons leaves the terminals in a state of deafferentation. A bolus injection (i.p.) of METH (30 mg/kg) induces apoptosis (TUNEL staining) in approximately 25% of neurons in the striatum at 24 h after METH. However, in contrast to apoptosis, depletion of TH (Western blotting) begins to appear at 24 h after METH in dorsal striatum while the ventral striatum is unaffected. The peak of TH depletion (approximately 80% decrease relative to control) occurs at 48 h after METH. Autoradiographic analysis of DAT sites showed that depletion begins to appear 24 h after METH and peaks at 2 days (approximately 60% depletion relative to control). Histological analysis of the induction of glial fibrillary acidic protein (GFAP) by METH in striatal astrocytes revealed an increase at 48 h after METH that peaked at 3 days. These data demonstrate that striatal apoptosis precedes the depletion (toxicity) of DA terminal markers in the striatum of mice, suggesting that the ensuing state of deafferentation of the DA terminals may contribute to their degeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043139      PMCID: PMC2886204          DOI: 10.1016/j.brainres.2005.04.089

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  43 in total

1.  Mechanisms for tolerance to methamphetamine effects.

Authors:  M P Gygi; S P Gygi; M Johnson; D G Wilkins; J W Gibb; G R Hanson
Journal:  Neuropharmacology       Date:  1996-06       Impact factor: 5.250

2.  A rapid and reversible change in dopamine transporters induced by methamphetamine.

Authors:  A E Fleckenstein; R R Metzger; J W Gibb; G R Hanson
Journal:  Eur J Pharmacol       Date:  1997-04-04       Impact factor: 4.432

3.  Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

Authors:  S B Berman; M J Zigmond; T G Hastings
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

4.  Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity.

Authors:  S Stephans; B Yamamoto
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

5.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.

Authors:  J M Wilson; K S Kalasinsky; A I Levey; C Bergeron; G Reiber; R M Anthony; G A Schmunk; K Shannak; J W Haycock; S J Kish
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

7.  Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

Authors:  J F Nash; B K Yamamoto
Journal:  Brain Res       Date:  1992-05-29       Impact factor: 3.252

8.  Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.

Authors:  C Pu; H W Broening; C V Vorhees
Journal:  Synapse       Date:  1996-08       Impact factor: 2.562

9.  Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity.

Authors:  J F Marshall; S J O'Dell; F B Weihmuller
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.

Authors:  C Pu; J E Fisher; G D Cappon; C V Vorhees
Journal:  Brain Res       Date:  1994-06-27       Impact factor: 3.252

View more
  34 in total

1.  Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Neuropharmacology       Date:  2015-01-31       Impact factor: 5.250

2.  Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Authors:  Bryan A Killinger; Anna Moszczynska
Journal:  J Neurochem       Date:  2015-12-10       Impact factor: 5.372

3.  Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamine.

Authors:  Nathalie Thiriet; Benjamin Gennequin; Virginie Lardeux; Claudia Chauvet; Mickael Decressac; Thierry Janet; Mohamed Jaber; Marcello Solinas
Journal:  Neurotox Res       Date:  2010-02-09       Impact factor: 3.911

4.  Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice.

Authors:  Jing Wang; Jesus A Angulo
Journal:  Synapse       Date:  2010-09-24       Impact factor: 2.562

5.  Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

Authors:  J P Q Zhu; W Xu; J A Angulo
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

6.  Connection between the striatal neurokinin-1 receptor and nitric oxide formation during methamphetamine exposure.

Authors:  Jing Wang; Wenjing Xu; Syed F Ali; Jesus A Angulo
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Toxic effect of methamphetamine on the retina of CD1 mice.

Authors:  Hong Lai; Huiyang Zeng; Cheng Zhang; Lin Wang; Mark O M Tso; Shenghan Lai
Journal:  Curr Eye Res       Date:  2009-09       Impact factor: 2.424

8.  The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Authors:  Lauriaselle Afanador; Ina Mexhitaj; Carolyn Diaz; Dalila Ordonez; Lisa Baker; Jesus A Angulo
Journal:  Brain Res       Date:  2013-03-19       Impact factor: 3.252

9.  Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performance.

Authors:  I K Tulloch; L Afanador; L Baker; D Ordonez; H Payne; I Mexhitaj; E Olivares; A Chowdhury; J A Angulo
Journal:  Neurotox Res       Date:  2014-02-19       Impact factor: 3.911

10.  Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.

Authors:  Irina N Krasnova; Zuzana Justinova; Bruce Ladenheim; Subramaniam Jayanthi; Michael T McCoy; Chanel Barnes; John E Warner; Steven R Goldberg; Jean Lud Cadet
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.